Serkan İlgün

12PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)OrthopaedicsAllergyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 29, 2025
Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

Neslihan Cabıoğlu, Hasan Karanlık, Abdullah Iğci

|Apr 15, 2025
Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.

Enver Özkurt, Cetin Ordu, Tolga Özmen

|Jan 02, 2025
Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance.

Zeynep Erdoğan İyigün, Tolga Ozmen, Serkan İlgün

|Apr 04, 2024
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy.

Tuba Kayan Tapan, Filiz Çelebi, Kourosh Yaghouti

|Oct 05, 2023
A Rare Complication Following Breast Conserving Surgery: Pyoderma Gangrenosum.

Glenn Costa, Serkan İlgün, David Pisani

|Aug 26, 2022
The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer.

Ahmet Serkan Ilgun, Fatma Aktepe, Onur Gonullu

Pageof 2

Frequent Collaborators

9 joint publications

Tuba Kayan Tapan

9 joint publications

Vahit Özmen

8 joint publications

Çetin Ordu

6 joint publications

Tomris Duymaz